ICU Bedside Dialysis is a service provided in the Intensive Care Unit (ICU) for patients with kidney failure who require dialysis while remaining in the ICU for critical care.

Patients may need bedside dialysis if they have acute kidney injury or chronic kidney disease that requires dialysis while they are critically ill or unstable.

Bedside dialysis is performed using specialized equipment and techniques to remove waste products and excess fluids from the blood while the patient remains in the ICU.

Bedside dialysis allows for continuous monitoring and treatment of critically ill patients without needing to transport them to a separate dialysis unit, which can be safer and more convenient.

Risks include infection, bleeding, and complications related to the dialysis procedure. The ICU team closely monitors patients to manage and minimize these risks.

The ANA Blot Test detects and identifies specific antinuclear antibodies (ANAs) in the blood, helping diagnose autoimmune diseases.

It is used to diagnose or rule out autoimmune disorders, assess disease progression, and investigate unexplained symptoms.

No fasting is required. Inform your healthcare provider about any medications or supplements you are taking.

Results are typically available within 2 to 7 days after the test.

The test can help diagnose autoimmune diseases such as lupus, scleroderma, and Sjögren’s syndrome, among others.

Recovery is usually quick, with most patients able to go home the same day. Full recovery takes about 1 to 2 weeks.